|
 ELN European Leukemia Network
162 Participating Centers in 33 Countries (1000 Researchers and Associates) are cooperating in the European Leukemia Net, funded by the 6th Framework Program of the European Community. It aims to strengthen and develop scientific and technological excellence in research and therapy of leukemia (CML, AML, ALL, CLL, MDS, CMPD) by integration of the leading national leukemia networks and their interdisciplinary partner groups in Europe. |
632 |
|
CML Advocates Network
The CML Advocates Network is a worldwide virtual network of non-profit organisations supporting patients with Chronic Myeloid Leukemia (CML) and their relatives. The network currently connects more than 50 patient groups in more than 40 countries on all continents. |
928 |
|
The Max Foundation
The Max Foundation is a US based NGO at the center of access to treatment for CML in developing countries. The organization is a main partner in the Glivec International Patient Assistance Program (GIPAP) as well as a key element in other treatment access programs, providing services to more than 22,000 CML patients annually. Additionally, The Max Foundation provides services to patient associations, partnering with patient leaders to establish and sponsor local patient groups. |
1127 |
|
European School of Hematology
ESH is a non profit institution for continuing education. It aims to promote and facilitate access to state of the art and cutting-edge knowledge in haematology and related disciplines, at the European level. |
564 |
|
Australian Leukaemia Foundation
Established in Queensland in 1975, the Australian Leukaemia Foundation is the only national organisation dedicated to the care and cure of patients and families living with leukaemias, lymphomas, myeloma and related blood disorders. The disorders include myelodysplastic syndromes, myeloproliferate disorders (PRV, ET, MF), waldenstroms, amyloidosis and aplastic anaemia. |
571 |
|
LOSEV
The Foundation for Children with Leukemia Health and Education, is a non-governmental and a non-profit public benefit organization in Turkey, which provides support to children affected by leukemia and their families. LOSEV’s primary goal is to provide permanent solutions to their problems. As 87% of the families of the children diagnosed with leukemia who are registered to LOSEV are from a low-income background and 11% have no income at all, LÖSEV provides complimentary treatment at LOSANTE; The Hospital for Children with Leukemia. Intensive treatment, accommodation and meals are completely free of charge for the patient and the accompanying mother. |
206 |
